Aarti Industries Defies Tariffs and Unveils Robust Growth
Aarti Industries Limited reported significant financial growth for Q2 FY26, despite challenges from new US tariffs on Indian chemical exports. The company achieved increased revenue and profit through market diversification, innovation, and operational efficiency. AIL also advanced sustainability goals and strategic partnerships, underscoring its global leadership in speciality chemicals.
- Country:
- India
Aarti Industries Limited (AIL), a leading speciality chemicals enterprise, has announced a robust financial performance for Q2 FY26 despite the complexities of new US tariffs on chemical exports from India.
The company recorded a 21% sequential increase in revenue, reaching ₹2250 crore, driven by improved volumes across key product categories. EBITDA surged by 36% to ₹292 crore, reflecting enhanced capacity utilisation and cost efficiency. AIL's net profit jumped by 150% to ₹105 crore, attributable to better operating leverage.
AIL continues its strategic expansion in Europe, the Middle East, and Africa while optimising its US strategy. The company's Zone IV Project and sustainability certifications further solidify its competitive position. As raw material costs stabilise and logistics improve, AIL anticipates continued margin expansion in the forthcoming quarters.
(With inputs from agencies.)
ALSO READ
Global Health Innovations and Challenges: Key Updates
Global Healthcare Shifts: Innovations, Challenges, and Conflicts
India Emerging as Global Hub for Precision Medicine and Biotech Innovation: Dr Jitendra Singh
Revamping Education in Himachal: CBSE Affiliation & Digital Innovations
Bharat Biotech: Celebrating Three Decades of Vaccine Innovation and Global Health Impact

